RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy

Qianyi Lu,Li Lu,Wei Chen,Haibing Chen,Xun Xu,Zhi Zheng
DOI: https://doi.org/10.1007/s00417-015-2985-3
2015-03-20
Abstract:BackgroundDiabetic retinopathy (DR) is a major cause of blindness in the working-age populations of developed countries, and effective treatments and prevention measures have long been the foci of study. Patients with DR invariably demonstrate impairments of the retinal microvascular endothelium. Many observational and preclinical studies have shown that angiogenesis and apoptosis play crucial roles in the pathogenesis of DR. Increasing evidence suggests that in DR, the small guanosine-5′-triphosphate-binding protein RhoA activates its downstream targets mammalian Diaphanous homolog 1 (mDia-1) and profilin-1, thus affecting important cellular functions, including cell morphology, motility, secretion, proliferation, and gene expression. However, the specific underlying mechanism of disease remains unclear.ConclusionThis review focuses on the RhoA/mDia-1/profilin-1 signaling pathway that specifically triggers endothelial dysfunction in diabetic patients. Recently, RhoA and profilin-1 signaling has attracted a great deal of attention in the context of diabetes-related research. However, the precise molecular mechanism by which the RhoA/mDia-1/profilin-1 pathway is involved in progression of microvascular endothelial dysfunction (MVED) during DR has not been determined. This review briefly describes each feature of the cascade before exploring the most recent findings on how the pathway may trigger endothelial dysfunction in DR. When the underlying mechanisms are understood, novel therapies seeking to restore the endothelial homeostasis comprised in DR will become possible.
ophthalmology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the specific mechanism of microvascular endothelial dysfunction (MVED) in diabetic retinopathy (DR). Specifically, the paper explores the role of the RhoA/mDia - 1/profilin - 1 signaling pathway in DR and how it triggers endothelial dysfunction. Although previous studies have shown that RhoA affects important functions such as cell morphology, movement, secretion, proliferation, and gene expression by activating its downstream targets mDia - 1 and profilin - 1, these specific mechanisms remain unclear. Therefore, the paper aims to further explore the role of this signaling pathway in microvascular endothelial dysfunction caused by diabetes, in order to provide new ideas and methods for the future treatment of DR.